giredestrant
Showing 1 - 10 of 10
Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)
Not yet recruiting
- Breast Cancer
- Giredestrant
- +2 more
- (no location specified)
Jun 13, 2023
Endometrial Cancer Trial (Giredestrant)
Not yet recruiting
- Endometrial Cancer
- Giredestrant
- (no location specified)
Feb 1, 2023
Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)
Not yet recruiting
- Breast Cancer
- Breast Cancer, Early-Onset
- Giredestrant
- Tamoxifen
- (no location specified)
Jan 18, 2023
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)
Not yet recruiting
- Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Giredestrant
- +6 more
- (no location specified)
Sep 26, 2023
Breast Cancer Trial (Giredestrant, Abemaciclib, Inavolisib)
Not yet recruiting
- Breast Cancer
- Giredestrant
- +2 more
- (no location specified)
Feb 1, 2023
Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)
Recruiting
- Locally Advanced or Metastatic Breast Cancer
- Phesgo
- +5 more
-
Los Angeles, California
- +21 more
Jul 25, 2022
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,
Recruiting
- Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- Giredestrant
- +5 more
-
Anchorage, Alaska
- +386 more
Jan 30, 2023
Early Breast Cancer Trial in Worldwide (Giredestrant, Anastrozole, Palbociclib)
Completed
- Early Breast Cancer
- Giredestrant
- +3 more
-
Beverly Hills, California
- +73 more
Jan 5, 2022
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Trial in Worldwide (Giredestrant, Abemaciclib,
Recruiting
- Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
- Giredestrant
- +9 more
-
Duarte, California
- +27 more
Jan 31, 2023